Worth Watching Stocks: Conns Inc.

Conns Inc. (NASDAQ:CONN) reported recently that it had grand openings of six stores during the final quarter of its 2016 fiscal year (November 2015–January 2016). The new stores underline the Company’s strategic growth and expanding footprint that now includes more than 100 retail locations in 12 states.

Conns Inc. (NASDAQ:CONN) belongs to Services sector. Its net profit margin is 2.90% and weekly performance is 5.37%. On last trading day company shares ended up at $15.69. Conns Inc. (NASDAQ:CONN) distance from 50-day simple moving average (SMA50) is 7.35%.

Janney Montgomery Scott began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR) in a report issued on Wednesday, The Fly reports. The brokerage set a “buy” rating on the biopharmaceutical company’s stock.

Nektar Therapeutics (NASDAQ:NKTR) shares moved down -4.35% in last trading session and ended the day at $11.00. NKTR Gross Margin is 84.80% and its return on assets is -15.80%. Nektar Therapeutics (NASDAQ:NKTR) quarterly performance is -26.42%.

Bristol-Myers Squibb Company (NYSE:BMY) announced that it has completed the previously announced sale of its HIV R&D portfolio to ViiV Healthcare, which includes a number of programs at different stages of discovery, preclinical and clinical development.

Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 9.50% and weekly performance is -0.18%. On last trading day company shares ended up at $62.07. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) is -3.82%.

Rite Aid Corporation (NYSE:RAD) announced that it will provide free talking prescription devices to customers with visual impairments. The technology will be available to customers at any of the approximately 4,600 Rite Aid pharmacies nationwide.

Rite Aid Corporation (NYSE:RAD) shares fell -0.13% in last trading session and ended the day at $7.94. RAD Gross Margin is 26.40% and its return on assets is 18.00%. Rite Aid Corporation (NYSE:RAD) quarterly performance is 3.52%.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that, it will present RBC Capital Markets Global Healthcare Conference February 23-24, 2016

On 23 February, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares fell -3.59% and was closed at $6.44. INO EPS growth in last 5 year was 14.20%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) year to date (YTD) performance is -4.17%.

Leave a Reply

Your email address will not be published. Required fields are marked *